Health News page: 1

Positive preclinical data of ORY-4001 for the treatment of Charcot-Marie-Tooth (CMT) disease presented at the 2023 Peripheral Nerve Society (PNS) Annual Meeting (ASEBIO - Asociación Española de Bioempresas)

Public Technologies | 2023-06-21, 13:59

) Partners Positive preclinical data of ORY-4001 for the treatment of Charcot-Marie-Tooth (CMT) disease presented at the 2023 Peripheral Nerve Society (PNS) Annual Meeting Comprehensively reversed disease progression symptoms in a CMT mice model. AseBio 21

Trevor Ombija falls in love again after healing from heartbreak

TheNewsHOOK | 2023-06-21, 13:48

Trevor Ombija falls in love again after healing from heartbreak ...

Breakthrough for multiple sclerosis sufferers may involve helpful hormone: ‘Patients should remain optimistic’

TheNewsHOOK | 2023-06-21, 13:48

Breakthrough for multiple sclerosis sufferers may involve helpful hormone: ‘Patients should remain optimistic’ ...

BioVie To Present of NE3017 in Alzheimer’s Disease Data at 83rd Scientific Sessions of the ...

Nasdaq Globe Newswire | 2023-06-21, 13:48

CARSON CITY, Nev., June 21, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or

PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients

no EC Victoria Advocate | 2023-06-21, 13:45

- Dose-dependent lowering of blood Huntingtin (HTT) protein levels at 12 weeks - - Favorable tolerability profile with no treatment-related serious adverse events or NfL spikes - - Conference call and webcast to be held June 21st at 8:00 am EDT - SOUTH

Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023

no EC Enid News & Eagle | 2023-06-21, 13:43

MELBOURNE, Australia and SAN FRANCISCO, June 21, 2023 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases,

Rgenta Therapeutics Announces Formation of Repeat Expansion Diseases Focused Scientific Advisory Board

PR Newswire | 2023-06-21, 13:38

CAMBRIDGE, Mass., June 21, 2023 /PRNewswire/ -- Rgenta Therapeutics today announced the formation of a Repeat Expansion Diseases (REDs) Focused Scientific Advisory Board (REDs SAB). REDs SAB is an esteemed group of preclinical and clinical experts who

Inhibikase Therapeutics Initiates Medical and Patient Awareness Campaign for its Phase 2 '201' Trial Evaluating IkT-148009 in Parkinson's Disease

PR Newswire | 2023-06-21, 13:24

- Company to highlight the '201' trial at multiple regional seminars for physicians - - Up to 61% of clinical sites actively screening patients by close of 2Q23 - BOSTON and ATLANTA, June 21, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq:

Mozart Therapeutics Presents Preclinical Data for MTX-101, a Novel CD8 Treg Network Modulator for Treatment of Autoimmune Disease, at FOCIS 2023 Annual Meeting

PR Newswire | 2023-06-21, 13:23

SEATTLE, June 21, 2023 /PRNewswire/ -- Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory disease, today announced the presentation of preclinical pharmacologic and tolerability data for MTX-101, a

OMRF discovery could lead to easier diagnosis of autoimmune disease

no EC The Duncan Banner | 2023-06-21, 12:57

OKLAHOMA CITY — A discovery at the Oklahoma Medical Research Foundation is paving a path toward a more accurate and less intrusive diagnosis of Sjögren’s disease, an autoimmune disorder affecting up to 4 million Americans. Currently, at least 30% of people

Polycystic Kidney Disease Drugs Market Analysis, Statistics By Top Manufacturers 2033

MENA FN | 2023-06-21, 12:53

(menafn - america news hour) research nester published a report titled –polycystic kidney disease drugs market: global demand analysis & opportunity outlook 2033– which delivers detailed overview ... ...

Recora And Arizona Heart Rhythm Center Open New Virtual Care Service For Heart Disease Patients

MENA FN | 2023-06-21, 12:53

(menafn - accesswire) the program expands virtual cardiac rehabilitation access to five provider service areas in arizona new york, ny / accesswire / june 21, 2023 / recora , the leader in ... ...

Urgent warning as ‘silent’ but deadly disease on the rise – the 3 signs you ...

The Sun | 2023-06-21, 12:25

CASES of a deadly non-alcoholic fatty-liver disease have been soaring over the past three decades, according to a new study. The condition, which causes inflammation of the organ, can lead to liver cancer and cirrhosis. 1 The US survey found rates of the

It starts with healing: Anishnabeg Outreach creates one stop shop for supports and education

CBC | 2023-06-21, 12:04

Anishnabeg Outreach are working on a new online hub they believe will help Indigenous communities to heal. AO Nest is still in the works, but once its complete late this fall, it'll be a one stop shop for supports and education. ...

Self-Healing Networks Market To Hit Usd 11.3 Billion At An 34.20% Cagr By 2032 - ...

MENA FN | 2023-06-21, 11:59

(menafn - globenewswire - nasdaq) new york, usa, june 21, 2023 (globe newswire) -- according to the research report published by market research future (mrfr),–self-healing networks market ... ...

Early disease detection made easier with AI

Hindustan Times | 2023-06-21, 11:56

Even as India’s health care system has progressed immensely over the years, the majority of patients succumb to death because of the late detection of disease. It’s a challenge that the country is still facing. According to the National Academy of Medical

Infectious Disease Plan publication (States of Guernsey)

Public Technologies | 2023-06-21, 11:54

) Wednesday 21 June 2023 This Infectious Disease Plan, the first such plan for the Bailiwick of Guernsey, looks to provide a coordinated approach to the management of infectious diseases locally, and their risks and consequences, with a focus on partnership

Interview: Global Development Initiative helps to heal post-pandemic world, says Turkish scholar

Xinhua | 2023-06-21, 11:48

ISTANBUL, June 21 (Xinhua) -- The Global Development Initiative (GDI) proposed by China is a timely guideline and roadmap for healing the post-pandemic world, a Turkish scholar has said. "Before the pandemic, there was already a slowdown in global development

Trunk calling: Chinese woman embraces ‘healing’ power of trees by cuddling them late at night ...

South China Morning Post | 2023-06-21, 11:36

The story of a woman in China who gains physical and psychological solace from hugging trees has gone viral on mainland social media. ...

FORESEE PHARMACEUTICALS PRESENTED POSTER ON MMP-12 INHBITOR, FP-020, IN GENETIC MODEL OF SARCOIDOSIS AT THE WASOG 2023 INTERNATIONAL CONFERENCE ON SARCOIDOSIS AND INTERSTITIAL LUNG DISEASES (ILDs)

PR Newswire | 2023-06-21, 11:28

Inhibiting MMP-12 with FP-020 attenuated macrophage infiltration, macrophage clustering, decreased fibrotic replacement, and reduced the number of activated fibroblasts. Mice with a conditional deletion of the Tsc2 gene in CD11c+ cells leading to chronic

Mannie and Rose: One couple's journey through Alzheimer's, 'a very tricky thief'

no EC The Brunswick News | 2023-06-21, 11:25

Mannie Rezende, a film buff, went to see a movie a few years ago and when it ended, he couldn't remember where he had parked his car. So he went home on a bus. Mannie, 71, loves to read, but ...

Skin Disease Spreading Among Livestock In Nuwara Eliya

MENA FN | 2023-06-21, 11:21

(menafn - colombo gazette) by k. krishanthan a skin disease is spreading among livestock in nuwara eliya and other parts of the central province. officials said that steps are being taken ... ...

Esme West helps others to heal

The Barton Chronicle | 2023-06-21, 11:18

by Matthew Wilson DERBY — The Northeast Kingdom may not seem

US FDA approves Argenx's drug for muscle-weakening disease

Gulf Daily News | 2023-06-21, 11:10

The US Food and Drug Administration has approved Argenx SE's under-the-skin injection for the treatment of a muscle-weakening genetic disease called generalized myasthenia gravis, the company said on Tuesday. The drug, branded as Vyvgart Hytrulo, is

Creative Commons / Marco Verch
Creative Commons
WN / james
Creative Commons
US FDA
WN / Emiko Silalahi
WN / Emiko Silalahi